|
| |
 |
|---|
|
Palliative Care Symposium: Clinical Decision Making and
Ethics in Advanced Cancer – Kuala Lumpur,
18 April 2007 |
| |
 |
|
From L to R: Dr Ednin Hamzah, Dr Noreen Chan, Dr Ghauri
Aggarwal and Dr Richard Lim who is the Clinical Specialist in
Palliative Care Unit of Selayang Hospital |
by
Dr Evelyn Ho
Hospis Malaysia and University
Malaya Medical Centre co-organised a palliative care symposium
focussed on clinical decision making and ethics in advanced cancer.
This was timely as technological and scientific breakthroughs have
enabled rapidly fatal cancers to be controlled and more and more
people were living with cancer, including advanced cancers. In other
words, technology has prolonged life and postponed death. This
translates to greater healthcare costs and an increasing “burden” on
already scarce resources.
Ethical principles used in medicine are that of autonomy (freedom of
self determination), beneficence (doing good), non-malfeasance
(doing no harm) and justice (fairness). Issues of informed
consent/consent to treatment options, duty of care of doctors,
justifying clinical investigations in advanced cancer, oncology
endpoints, ethical issues in truth telling, compassionate care,
therapeutic options in the dying, ethical considerations in children
with advanced illness and euthanasia – “dignified death or
simplified killing?” were covered in this one day symposium.
Consultant Physician in Palliative Medicine and Head of Department
of the Palliative Care Unit, Concord Hospital, Sydney, Australia -
Dr Ghauri Aggarwal emphasised the following point to the audience,
which was made up of paramedical staff, doctors interested and those
practicing palliative care medicine primarily: Doctors should not
say “we can’t do anything more for you” as there was still a lot
more to do for support and care! Yet the issue of medical futility
had to be recognised – that is, when a doctor should not provide
futile medical treatment. Futile medical treatment would include
treatment that would not produce the benefits sought by the patient;
that results in temporary and fleeting benefits that do not improve
conditions and that which prolongs the dying process and offers no
realistic change of improvement. Futile medical treatment could be
distinguished as quantitative or qualitative.
“End of Life” discussion and what may happen must be discussed as
soon as possible. Realistic discussion of cardiopulmonary
resuscitation and the outcome was important so that caregivers and
relatives would not feel guilty. A documentation of “no active
resuscitation” does not mean “no more care” either. It was important
for the doctor primarily in charge of a patient to communicate the
end of life care plans to his/her colleagues, especially during off
duty hours or in an emergency situation.
In addition to Dr Ghauri Aggarwal, the faculty included:
Dr Rosalie Shaw, Executive Director of
Asia Pacific Hospice
Palliative Care Network, Singapore; Professor Norchaya Talib,
PhD, Faculty of Law, University Malaya; Dr Noreen Chan, Medical
Director,
Dover Park Hospice, Singapore; Dr Anita Bustam, Head of
Department of Radiotherapy & Oncology, University Malaya Medical
Centre and Dr Ednin Hamzah, CEO/Medical Director of
Hospis
Malaysia
|
|---|
|
|
>>>
Click Here to return to news headlines |
|
|
Copyright © 2001-2008 College of Radiology, Academy of Medicine of Malaysia All Rights Reserved
Terms of Use Last Updated:
Monday, 21 January 2008 |
|